Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Etiometry

Explore full profile

Transforming critical care data into clinical insights

Boston, United StatesFounded 2010Health Tech & Medtech
Valuation $50–100M Last recorded · 2021
Revenue $1–10M Latest reported FY
Headcount <100 Current team size
Total funding $10–50M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Etiometry and the history behind them.

About Etiometry

Etiometry Inc. specializes in analytics-based clinical decision support software designed for intensive care units (ICUs). The company leverages advanced data aggregation, integration, and analytics platforms to provide clinicians with actionable insights that improve patient outcomes, enhance the efficiency of care delivery, and reduce healthcare costs. Etiometry's software aggregates data from multiple sources, synthesizes it to reveal potential risks, and presents it in a physiological context, enabling clinicians to make more informed decisions. The primary clients are hospitals and healthcare providers operating in the critical care market. The business model revolves around a subscription-based service, where clients pay for access to the software and its continuous updates. Revenue is generated through these subscriptions and additional services such as training and support.

Source: Dealroom company data

At a glance

Status
Operational
Founded
2010
Headquarters
Boston, United States
Employees
54
Open positions
None listed
Dealroom signal
72.3/100
Industry
Health, Enterprise Software
Sub-industry
Health Platform
Sector
Health Tech & Medtech, Predictive Analytics, Patient Care, Spinout, DT and LS, science-based
Technology
Big Data, Deep Tech
Business model
SaaS
Client focus
b2b

Funding history

9 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
DEBT✓Debt Apr 2024 $10M — Undisclosed ↗
SERIES A✓Equity / VC Jun 2021 $9M $36M Shepherd Kaplan Krochuck · Shamrock Holdings · Shepherd Kaplan —
Showing the latest 2 of 9 recorded eventsBook a demo for the full funding history →

Financials

Revenue over time

Revenue, earnings and other financial measures where available. Years marked “E” are estimates.

YearRevenueGrowth
2026
2025
2024
2023
2022
2021
2020 —
Company filings, research estimates and Dealroom dataBook a demo for the full financial model →

Growth signals

Etiometry website traffic

Latest recorded traffic for Etiometry is 5K monthly website visits, up 6.4% over the last three months. Etiometry's team declined 8.5% over the past year.

Latest monthly visits5K 3-month web change+6.4% 1-year team growth-8.5%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Investors

9 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed2 investors entered at this stage

  • US Department of War
  • US Department of Health and Human Services

Series A3 investors entered at this stage

  • Shepherd Kaplan
  • Shepherd Kaplan Krochuck
  • Shamrock Holdings

Other known investors4 additional known investors

Team profiled 10 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 5 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
2 countries with
team presence
🇺🇸 United States97.8%
🇦🇪 United Arab Emirates2.2%
2 countries shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Etiometry on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Etiometry’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.